Morishita Jintan Co., Ltd. (4524.T)
JPY 2065.0
(-0.24%)
JPY 2065.0
(-0.24%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.18 Billion JPY | 42.25% |
| 2022 | 2.23 Billion JPY | 20.44% |
| 2021 | 1.85 Billion JPY | 20.01% |
| 2020 | 1.54 Billion JPY | -19.03% |
| 2019 | 1.91 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.01 Billion JPY | -5.24% |
| 2023 Q2 | 2.71 Billion JPY | 4.47% |
| 2023 Q4 | 3.18 Billion JPY | -0.84% |
| 2023 Q3 | 3.21 Billion JPY | 18.52% |
| 2023 Q1 | 2.59 Billion JPY | 15.86% |
| 2023 FY | 3.18 Billion JPY | 42.25% |
| 2022 Q2 | 1.98 Billion JPY | 0.0% |
| 2022 Q4 | 2.23 Billion JPY | 9.86% |
| 2022 Q3 | 2.03 Billion JPY | 2.83% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | 52.583% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.737% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 97.239% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 95.094% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -58.771% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 91.857% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 81.447% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 98.176% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 84.959% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 89.481% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 77.574% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | 70.295% |
| Tsumura & Co. | 117.61 Billion JPY | 97.292% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 87.888% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | 70.35% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 96.849% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 83.558% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 78.019% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 94.043% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -63.166% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 84.753% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -1272.667% |
| MedRx Co., Ltd | 10 Million JPY | -31750.0% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -99.485% |
| Solasia Pharma K.K. | 122 Million JPY | -2510.656% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -50033.795% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 84.389% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 96.815% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -6817.146% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 96.351% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -40.54% |